206 related articles for article (PubMed ID: 12523893)
1. Visual loss in patients with cytomegalovirus retinitis and acquired immunodeficiency syndrome before widespread availability of highly active antiretroviral therapy.
Holbrook JT; Jabs DA; Weinberg DV; Lewis RA; Davis MD; Friedberg D;
Arch Ophthalmol; 2003 Jan; 121(1):99-107. PubMed ID: 12523893
[TBL] [Abstract][Full Text] [Related]
2. Combination foscarnet and ganciclovir therapy vs monotherapy for the treatment of relapsed cytomegalovirus retinitis in patients with AIDS. The Cytomegalovirus Retreatment Trial. The Studies of Ocular Complications of AIDS Research Group in Collaboration with the AIDS Clinical Trials Group.
Arch Ophthalmol; 1996 Jan; 114(1):23-33. PubMed ID: 8540847
[TBL] [Abstract][Full Text] [Related]
3. Rhegmatogenous retinal detachment in patients with cytomegalovirus retinitis: the Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial. The Studies of Ocular Complications of AIDS (SOCA) Research Group in Collaboration with the AIDS Clinical Trials Group (ACTG).
Am J Ophthalmol; 1997 Jul; 124(1):61-70. PubMed ID: 9222234
[TBL] [Abstract][Full Text] [Related]
4. Causes of visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
Thorne JE; Jabs DA; Kempen JH; Holbrook JT; Nichols C; Meinert CL;
Ophthalmology; 2006 Aug; 113(8):1441-5. PubMed ID: 16781775
[TBL] [Abstract][Full Text] [Related]
5. Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial. 4. Visual outcomes. Studies of Ocular Complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group.
Ophthalmology; 1994 Jul; 101(7):1250-61. PubMed ID: 8035989
[TBL] [Abstract][Full Text] [Related]
6. Long-term visual morbidity of cytomegalovirus retinitis in patients with acquired immune deficiency syndrome.
Roarty JD; Fisher EJ; Nussbaum JJ
Ophthalmology; 1993 Nov; 100(11):1685-8. PubMed ID: 8233395
[TBL] [Abstract][Full Text] [Related]
7. Retinal detachment risk in cytomegalovirus retinitis related to the acquired immunodeficiency syndrome.
Kempen JH; Jabs DA; Dunn JP; West SK; Tonascia J
Arch Ophthalmol; 2001 Jan; 119(1):33-40. PubMed ID: 11146724
[TBL] [Abstract][Full Text] [Related]
8. Long-term Outcomes of Cytomegalovirus Retinitis in the Era of Modern Antiretroviral Therapy: Results from a United States Cohort.
Jabs DA; Ahuja A; Van Natta ML; Lyon AT; Yeh S; Danis R;
Ophthalmology; 2015 Jul; 122(7):1452-63. PubMed ID: 25892019
[TBL] [Abstract][Full Text] [Related]
9. Visual field loss in patients with cytomegalovirus retinitis.
Thorne JE; Van Natta ML; Jabs DA; Duncan JL; Srivastava SK;
Ophthalmology; 2011 May; 118(5):895-901. PubMed ID: 21146225
[TBL] [Abstract][Full Text] [Related]
10. Foscarnet-Ganciclovir Cytomegalovirus Retinitis Trial: 5. Clinical features of cytomegalovirus retinitis at diagnosis. Studies of ocular complications of AIDS Research Group in collaboration with the AIDS Clinical Trials Group.
Am J Ophthalmol; 1997 Aug; 124(2):141-57. PubMed ID: 9262538
[TBL] [Abstract][Full Text] [Related]
11. Risk of vision loss in patients with cytomegalovirus retinitis and the acquired immunodeficiency syndrome.
Kempen JH; Jabs DA; Wilson LA; Dunn JP; West SK; Tonascia JA
Arch Ophthalmol; 2003 Apr; 121(4):466-76. PubMed ID: 12695243
[TBL] [Abstract][Full Text] [Related]
12. Incidence of and risk factors for visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
Thorne JE; Jabs DA; Kempen JH; Holbrook JT; Nichols C; Meinert CL;
Ophthalmology; 2006 Aug; 113(8):1432-40. PubMed ID: 16766032
[TBL] [Abstract][Full Text] [Related]
13. Cytomegalovirus retinitis and HIV: Case reviews from KwaZulu-Natal Province, South Africa.
Hassan-Moosa R; Chinappa T; Jeena L; Visser L; Naidoo K
S Afr Med J; 2017 Sep; 107(10):843-846. PubMed ID: 29022526
[TBL] [Abstract][Full Text] [Related]
14. Comparison of treatment regimens for cytomegalovirus retinitis in patients with AIDS in the era of highly active antiretroviral therapy.
Jabs DA; Ahuja A; Van Natta M; Dunn JP; Yeh S;
Ophthalmology; 2013 Jun; 120(6):1262-70. PubMed ID: 23419804
[TBL] [Abstract][Full Text] [Related]
15. Immune recovery uveitis in AIDS patients with cytomegalovirus retinitis treated with highly active antiretroviral therapy in Venezuela.
Arevalo JF; Mendoza AJ; Ferretti Y
Retina; 2003 Aug; 23(4):495-502. PubMed ID: 12972761
[TBL] [Abstract][Full Text] [Related]
16. Cystoid macular oedema and cytomegalovirus retinitis in patients with HIV disease treated with highly active antiretroviral therapy.
Cassoux N; Lumbroso L; Bodaghi B; Zazoun L; Katlama C; LeHoang P
Br J Ophthalmol; 1999 Jan; 83(1):47-9. PubMed ID: 10209434
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal study of the ocular complications of AIDS: 2. Ocular examination results at enrollment.
Jabs DA; Van Natta ML; Holbrook JT; Kempen JH; Meinert CL; Davis MD;
Ophthalmology; 2007 Apr; 114(4):787-93. PubMed ID: 17210182
[TBL] [Abstract][Full Text] [Related]
18. Incidence Rates and Risk Factors for Vision Loss among AIDS-Related Cytomegalovirus Retinitis Patients in Southern Thailand.
Sittivarakul W; Seepongphun U
Ocul Immunol Inflamm; 2018; 26(1):82-89. PubMed ID: 28323489
[TBL] [Abstract][Full Text] [Related]
19. MSL-109 adjuvant therapy for cytomegalovirus retinitis in patients with acquired immunodeficiency syndrome: the Monoclonal Antibody Cytomegalovirus Retinitis Trial. The Studies of Ocular Complications of AIDS Research Group. AIDS Clinical Trials Group.
Arch Ophthalmol; 1997 Dec; 115(12):1528-36. PubMed ID: 9400786
[TBL] [Abstract][Full Text] [Related]
20. Non-cytomegalovirus ocular opportunistic infections in patients with acquired immunodeficiency syndrome.
Gangaputra S; Drye L; Vaidya V; Thorne JE; Jabs DA; Lyon AT;
Am J Ophthalmol; 2013 Feb; 155(2):206-212.e5. PubMed ID: 23068916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
